MedTrace Logo

Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants

NCT03320603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 397

Last updated 2021-07-27

No results posted yet for this study

Summary

The study is assessing the impact of an expert eCRF on the management of severe bleeding in the administration of Prothrombin Complex Concentrate in patients treated with oral anticoagulants and adherence to recommendations or experts' consensus

Conditions

  • Emergency Care for Severe Bleeding While on Anticoagulants

Interventions

OTHER

Expert eCRF

An expert eCRF will be used to guide physicians during the management of patients treated with Vitamin K Agonist or Direct Oral Anticoagulant admitted in emergency units for severe bleeding.

OTHER

Prothrombin Complex Concentrate

Prothrombin Complex Concentrate given as standard of care

Sponsors & Collaborators

  • Octapharma

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-13
Primary Completion
2020-12-20
Completion
2020-12-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320603 on ClinicalTrials.gov